AOD 9604 does not
Scientific and Official Sources PubChem: BPC-157 sequence-related identity, molecular formula and calculated molecular weight United States FDA: 2026 briefing document for BPC-157 free peptide and BPC-157 acetate ClinicalTrials.gov: BPC-157 safety and pharmacokinetics Phase I registry record Sikiric and colleagues: BPC-157, L-arginine and nitric-oxide-system research Lojo and colleagues: experimental use of BPC-157, L-NAME and L-arginine as separate agents McGuire and colleagues: review of BPC-157 evidence and safety uncertainties United States FDA: safety concerns involving certain bulk substances, including BPC-157 MHRA: borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 World Anti-Doping Agency: 2026 Prohibited List
Most clinical data focuses on weight loss and glycemic control with standard dosing, not on the safety of extended fasting periods
Employers that provide their workers with health insurance can also choose to pay extra if they'd like to include GLP-1 for weight loss coverage in their health plans or opt out entirely
Lets break down what they are, what they do, and how they might help you feel your best
Peptides may also have potential side effects, such as nausea, vomiting, and diarrhea
